By using tumor samples obtained from our cancer center and expression data obtained from independent dataset GSE44295, our following validation studies proved for the first time that low expression of SPTBN1 was directly linked to an unfavorable clinical prognosis in KIRC patients, and a favorable clinical prognosis in UVM cases (Figs. 7 and 8). The gene discussed is SPTBN1; the disease is neoplasm.